PRDX2 and neoplasm: Then, we rescued PRDX2 WT or C51S mutant expression in PRDX2-KO cancer cells (Figure 6, A and B) and assessed cancer cell phenotype by performing clonogenic and tumor spheroid assays (Figure 6, C and D).